Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Assets Average: 2011-2025

Historic Assets Average for Adma Biologics (ADMA) over the last 10 years, with Sep 2025 value amounting to $563.5 million.

  • Adma Biologics' Assets Average rose 46.94% to $563.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $563.5 million, marking a year-over-year increase of 46.94%. This contributed to the annual value of $408.9 million for FY2024, which is 20.69% up from last year.
  • According to the latest figures from Q3 2025, Adma Biologics' Assets Average is $563.5 million, which was up 5.44% from $534.5 million recorded in Q2 2025.
  • Adma Biologics' 5-year Assets Average high stood at $563.5 million for Q3 2025, and its period low was $221.7 million during Q1 2021.
  • For the 3-year period, Adma Biologics' Assets Average averaged around $408.7 million, with its median value being $363.6 million (2024).
  • Per our database at Business Quant, Adma Biologics' Assets Average declined by 1.33% in 2024 and then spiked by 46.98% in 2025.
  • Over the past 5 years, Adma Biologics' Assets Average (Quarterly) stood at $257.4 million in 2021, then grew by 26.05% to $324.5 million in 2022, then rose by 4.49% to $339.1 million in 2023, then grew by 29.66% to $439.6 million in 2024, then spiked by 46.94% to $563.5 million in 2025.
  • Its last three reported values are $563.5 million in Q3 2025, $534.5 million for Q2 2025, and $499.6 million during Q1 2025.